These specialist services remove harmful, disease-forming proteins, chemicals, or cells from patients’ blood
Life-saving patient care
Therapeutic Apheresis is one of our flagship services, and the only one that deals with patients directly. We treat approximately 1,600 adults and children every year from eight dedicated therapeutic units across the country.
The information on these pages is primarily for Therapeutic Apheresis patients, donors, carers and visitors.
If you are a clinician, you may find the following links useful:
Our therapeutic apheresis treatments
We provide adults and children with access to a portfolio of apheresis services from across a range of clinical specialities. Treatments include plasma exchange for neurology, renal and haematology patients; automated red cell exchange in support of patients suffering with sickle cell disease and stem cell retrieval for bone marrow transplantation.
Where can you receive treatment?
We currently provide Therapeutic Apheresis Services (TAS) from eight units across England. These are based within NHS Trusts. Each of our units is clinically led by a consultant and lead nurse, and supported by a team of experienced TAS nurses. Each unit offers a range of specialist treatments for patients suffering with a wide range of clinical conditions.
Therapeutic apheresis treatments usually take place at one of our eight specialist units and are generally painless. For more information on what to expect as a patient, please visit our patient page or contact your local TAS unit, hospital clinician, or GP.
You're in safe hands
- Our facilities are regulated by the Care Quality Commission, Human Tissue Authority and the Joint Accreditation Committee - ISCT (Europe) & EBMT (JACIE)
- We have a longstanding exemplary regulatory performance history
- Each of our units are co-located in NHS Trust environments to provide continuity of care and access to clinical support services